Overview
Join us at the UK National QPPV Forum - Celebrating the 5th Edition, In-Person
Adapting to Change: Navigating New Regulatory Requirements in the UK
The UK regulatory landscape continues to evolve rapidly, with new legislation and frameworks shaping pharmacovigilance and clinical operations. This year’s UK National QPPV Workshop will provide practical insights and updates on the latest developments impacting QPPVs and PV professionals across the UK.
Join regulators, industry experts, and your peers to discuss how to navigate recent and upcoming changes - including the implementation of the UK Clinical Trials Regulation, updates on MHRA inspection trends, and the latest device post-marketing requirements.
You’ll also gain perspectives on RMP effectiveness assessments, digitalisation of educational materials, and data protection obligations within the UK framework.
This annual workshop remains a trusted platform for QPPVs to share experiences, learn from MHRA representatives, and collaborate on solutions for real-world compliance and operational excellence in the UK market.
Program Committee
-
Elspeth McIntosh, MBA, RN Director
Castle Pharmacovigilance Ltd, United Kingdom -
Sophie Radicke, MSC Head of GPvP and Senior Pharmacovigilance Inspector
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom -
Louise Woodward, PHD UK QPPV and Local Safety Responsible
Roche Products Ltd, United Kingdom -
Helen Fiddes Head of Country Pharmacovigilance, UK and Ireland
Bristol-Myers Squibb, United Kingdom -
Lauren East Head, Pharmacovigilance UK
Abbvie, United Kingdom -
Rory Littlebury Head of PVSO and QPPV Office
GlaxoSmithKline (GSK), United Kingdom
Have an account?